Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper.
Valentini V, Marijnen C, Beets G, Bujko K, De Bari B, Cervantes A, Chiloiro G, Coco C, Gambacorta MA, Glynne-Jones R, Haustermans K, Meldolesi E, Peters F, Rödel C, Rutten H, van de Velde C, Aristei C. Valentini V, et al. Among authors: gambacorta ma. Radiother Oncol. 2020 Jan;142:6-16. doi: 10.1016/j.radonc.2019.07.001. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431374
Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer.
Pacelli F, Di Giorgio A, Papa V, Tortorelli AP, Covino M, Ratto C, Bossola M, Valentini V, Sofo L, Miccichè F, Gambacorta MA, Doglietto GB. Pacelli F, et al. Among authors: gambacorta ma. Dis Colon Rectum. 2004 Feb;47(2):170-9. doi: 10.1007/s10350-003-0028-3. Dis Colon Rectum. 2004. PMID: 15043286 Clinical Trial.
Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study.
Gambacorta MA, Valentini V, Morganti AG, Mantini G, Miccichè F, Ratto C, Di Miceli D, Rotondi F, Alfieri S, Doglietto GB, Vargas JG, De Paoli A, Rossi C, Cellini N. Gambacorta MA, et al. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):130-8. doi: 10.1016/j.ijrobp.2004.02.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337548 Clinical Trial.
Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Magistrelli P, Picciocchi A, Cellini N. Gambacorta MA, et al. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):139-48. doi: 10.1016/j.ijrobp.2004.01.051. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337549 Clinical Trial.
Biological optimization of the dose in rectal carcinoma.
Valentini V, Morganti AG, Mantini G, Petrone A, Tagliaferri L, Gambacorta MA. Valentini V, et al. Among authors: gambacorta ma. Rays. 2004 Jul-Sep;29(3):343-9. Rays. 2004. PMID: 15603308 Review.
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM). Valentini V, et al. Among authors: gambacorta ma. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16414206 Clinical Trial.
294 results